Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone

BACKGROUND: We evaluate trade-offs between quality of life (QoL) and survival improvement for two chemotherapy regimens in advanced breast cancer. We also report on the long-term survival of patients in the ANZ 8614 clinical trial. METHODS: A total of 391 patients were randomized to mitoxantrone (14...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chee Khoon, Gebski, Val J, Coates, Alan S, Veillard, Anne-Sophie, Harvey, Vernon, Tattersall, Martin HN, Byrne, Michael J, Brigham, Brian, Forbes, John, Simes, R John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765591/
https://www.ncbi.nlm.nih.gov/pubmed/24024086
http://dx.doi.org/10.1186/2193-1801-2-391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765591/
https://www.ncbi.nlm.nih.gov/pubmed/24024086
http://dx.doi.org/10.1186/2193-1801-2-391

Ejemplares similares